The in-vitro effect of famotidine on sars-cov-2 proteases and virus replication
Abstract The lack of coronavirus-specific antiviral drugs has instigated multiple drug repurposing studies to redirect previously approved medicines for the treatment of SARS-CoV-2, the coronavirus behind the ongoing COVID-19 pandemic. A recent, large-scale, retrospective clinical study showed that...
Enregistré dans:
Auteurs principaux: | Madeline Loffredo, Hector Lucero, Da-Yuan Chen, Aoife O’Connell, Simon Bergqvist, Ahmad Munawar, Asanga Bandara, Steff De Graef, Stephen D. Weeks, Florian Douam, Mohsan Saeed, Ali H. Munawar |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e07d8710ce004328ab2ec83a48a74f35 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Tizanidine-induced acute severe cystitis in a female taking famotidine
par: Poudel RR, et autres
Publié: (2015) -
Effect of famotidine on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor
par: Upreti VV, et autres
Publié: (2013) -
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
par: Wayne Vuong, et autres
Publié: (2020) -
Effect of famotidine on hospitalized patients with COVID-19: A systematic review and meta-analysis.
par: Leonard Chiu, et autres
Publié: (2021) -
Effect of famotidine on hospitalized patients with COVID-19: A systematic review and meta-analysis
par: Leonard Chiu, et autres
Publié: (2021)